🎗️Лента новостей
Онкология
В России создали магнитную жидкость для лечения опухолей
В России создали магнитную жидкость для лечения опухолей Наука Mail
Онкология
Data Safety Monitoring Board Recommends Continuing BriaCell's Phase 3 Metastatic Breast Cancer Study
Data Safety Monitoring Board Recommends Continuing BriaCell's Phase 3 Metastatic Breast Cancer Study Investing News Network
Онкология
Advancing Childhood Cancer Research: Q&A with Dr. Brigitte Widemann
Advancing Childhood Cancer Research: Q&A with Dr. Brigitte Widemann cancer.gov
Онкология
The first patient gets Janux's new immune treatment in a prostate cancer trial.
The first patient gets Janux's new immune treatment in a prostate cancer trial. Stock Titan
Онкология
Emerging CELMoDs in Multiple Myeloma
Онкология
AZ's Etcamah falls short in first-line breast cancer trial
AZ's Etcamah falls short in first-line breast cancer trial pharmaphorum
Онкология
A breast cancer trial gets a seventh recommendation to continue
A breast cancer trial gets a seventh recommendation to continue Stock Titan
Онкология
Perspective Therapeutics Enters Cancer Clinical Trial Collaboration With Merck; Shares Up Pre-Bell
Perspective Therapeutics Enters Cancer Clinical Trial Collaboration With Merck; Shares Up Pre-Bell marketscreener.com
Онкология
Researchers identify medulloblastoma molecular groups using noninvasive MRI spectroscopy
Research by Stefan Blüml, Ph.D., and colleagues investigates the use of in vivo proton magnetic resonance spectroscopy (¹H-MRS) to identify medulloblastoma molecular subgroups before surgery, a noninvasive alternative to surgical tumor sampling that could help support treatment planning at an earlier stage. The study…
Онкология
Иллюзия чистоты крови обманывала онкологов годами: скрытый механизм опухоли диктует финал терапии
Иллюзия чистоты крови обманывала онкологов годами: скрытый механизм опухоли диктует финал терапии Правда.Ру
🎗️
Онкология
Most Appendix Cancer Patients Can Skip Chemo, Study Says
Most Appendix Cancer Patients Can Skip Chemo, Study Says U.S. News & World Report
Онкология
Персонализированная вакцина против рака на основе ИИ прошла ключевое испытание
Персонализированная вакцина против рака на основе ИИ прошла ключевое испытание El.kz